A Meta- and Trial Sequential Analysis by Schwendicke, Falk et al.
RESEARCH ARTICLE
Periodontal Treatment for Preventing
Adverse Pregnancy Outcomes: A Meta- and
Trial Sequential Analysis
Falk Schwendicke1*, Nadeem Karimbux2, Veerasathpurush Allareddy3, Christian Gluud4
1 Department of Operative and Preventive Dentistry, Charité—Universitätsmedizin Berlin, Berlin, Germany,
2 Tufts University School of Dental Medicine, Boston, 3 Department of Orthodontics, College of Dentistry—
The University of Iowa, Iowa City, 4 Copenhagen Trial Unit, Centre for Clinical Intervention Research,




Periodontal treatment might reduce adverse pregnancy outcomes. The efficacy of peri-
odontal treatment to prevent preterm birth, low birth weight, and perinatal mortality was eval-
uated using meta-analysis and trial sequential analysis.
Methods
An existing systematic review was updated and meta-analyses performed. Risk of bias, het-
erogeneity, and publication bias were evaluated, and meta-regression performed. Sub-
group analysis was used to compare different studies with low and high risk of bias and
different populations, i.e., risk groups. Trial sequential analysis was used to assess risk of
random errors.
Results
Thirteen randomized clinical trials evaluating 6283 pregnant women were meta-analyzed.
Four and nine trials had low and high risk of bias, respectively. Overall, periodontal treat-
ment had no significant effect on preterm birth (odds ratio [95% confidence interval] 0.79
[0.57-1.10]) or low birth weight (0.69 [0.43-1.13]). Trial sequential analysis demonstrated
that futility was not reached for any of the outcomes. For populations with moderate occur-
rence (<20%) of preterm birth or low birth weight, periodontal treatment was not efficacious
for any of the outcomes, and trial sequential analyses indicated that further trials might be
futile. For populations with high occurrence (20%) of preterm birth and low birth weight,
periodontal treatment seemed to reduce the risk of preterm birth (0.42 [0.24-0.73]) and low
birth weight (0.32 [0.15-0.67]), but trial sequential analyses showed that firm evidence was
not reached. Periodontal treatment did not significantly affect perinatal mortality, and firm
evidence was not reached. Risk of bias, but not publication bias or patients’ age modified
the effect estimates.
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Conclusions
Providing periodontal treatment to pregnant women could potentially reduce the risks of
perinatal outcomes, especially in mothers with high risks. Conclusive evidence could not be
reached due to risks of bias, risks of random errors, and unclear effects of confounding. Fur-
ther randomized clinical trials are required.
Introduction
Bacterial infection and subsequent immunological reactions are hypothesized to cause adverse
pregnancy outcomes like preterm birth, low birth weight, and perinatal mortality [1, 2]. Peri-
odontal disease is discussed as one possible causal factor for adverse pregnancy outcomes, caus-
ing systemically increased levels of endotoxins, inflammatory cytokines, and oxidative
stressors, which might negatively affect maternal and neonatal health [3, 4]. There is ambigu-
ous evidence if mechanical subgingival debridement (‘periodontal treatment’), that is scaling
and root planning, can reduce adverse pregnancy outcomes. A recently published systematic
review and meta-analysis found significantly reduced risks of preterm birth (odds ratio (OR)
[95% confidence interval] 0.66 [0.54–0.80]) and low birth weight (0.48 [0.30–0.78]) in popula-
tions with high occurrence of adverse pregnancy outcomes, whilst the estimates for those with
moderate occurrence of adverse events and all patients were statistically non-significant [1].
Moreover, outcomes of periodontal treatment might be affected by patient- and study-related
confounders, like age of the patient and risks of bias in the trials [1, 2]. Other reviews confirm
the potential of periodontal treatment to reduce adverse pregnancy outcomes, but also raise
doubts as to the generalizability of these findings and the level of reached evidence [1–4].
The evidence strength stemming from such traditional frequentistic meta-analyses might be
additionally reduced as they do not fully account for random errors, that is spuriously signifi-
cant results (type I errors) or spuriously insignificant results (type II errors), which may occur
due to sparse data and repeated significance testing [5, 6]. Frequentistic meta-analyses ought to
be based on an a priori calculated required information size (equivalent to the sample size in a
randomized clinical trial), and meta-analyses conducted before the required information size is
reached need to be assessed with more stringent statistical thresholds than usual in order to
control spuriously significant results [5, 6]. Additionally, non-significance is often regarded as
a matter of lack of effect, whilst truly, it may just be a type II error due to lack of statistical
power before reaching the required information size [5, 6]. Trial sequential analysis accounts
for such risks by calculating the required information size (RIS) and using trial sequential mon-
itoring boundaries, which adjust significance levels depending on the data availability when
testing for superiority [5, 6].
Since it remains unclear if periodontal treatment during pregnancy is efficacious to prevent
preterm birth (PTB,<37th week), low birth weight (LBW,<2500 g), and spontaneous abor-
tions or stillbirths (perinatal mortality, PNM), we conducted an updated meta-analysis, includ-
ing a reassessment of bias risks and meta-regression to assess possible effects of confounders,
and trial sequential analysis to assess the risks of random errors.
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Methods
Randomized clinical trials and risk of bias
Our analyses were based on the review by Kim et al. including 11 randomized clinical trials [1].
Since the publication of this study, two more randomized clinical trials evaluating intra-preg-
nancy periodontal treatment for preventing adverse pregnancy outcomes have been published
[7, 8]. Periodontal treatment was defined as subgingival scaling and root-planing with or with-
out adjunctive use of antibiotics. The control group should have received all pre- and post-op-
erative care (i.e., supragingival scaling, oral hygiene education, antibiotics) similarly to the
experimental test group, only PT was not to be provided. PTB and LBWwere assessed as events
per total life births, where possible. We performed risk of bias assessment as outlined by the
Cochrane Collaboration, trial with unclear or high risk of bias being assessed as trials with high
risk of bias [9]. Whilst blinding of participants or personnel was assessed, this domain was not
used for judging a trial’s overall risk of bias, since neither operators nor patients could have
been ethically and effectively blinded. Risk of bias assessment was conducted by two authors in-
dependently, and a third author was contacted to reach consensus in case of disagreements.
Meta-analysis and meta-regression
Conventional meta-analysis was performed with random-effects models using the DerSimo-
nian-Laird estimator of variance [9], with odds ratio and 95% confidence intervals (95% CI)
being calculated. Heterogeneity was assessed using both Cochrane’s Q and I2-statistics [10].
Publication bias was assessed graphically and statistically via funnel plot analysis and one-
sided Egger’s regression test [11]. If publication bias was indicated, trim-and-fill was used for
adjusting odds ratios [12].
Subgroups of trials with low and high risk of bias and trial with moderate (<20% for PTB,
<20% LBW,<1% for PNM) or high (20% for PTB,20% for LBW,1% for PNM) control
group event proportions were analyzed separately. Thus, the latter was used to define risk
groups. It should be noted that such categorization is not biologically grounded, but has been
used before to assess differential treatment effects of periodontal treatment on adverse preg-
nancy outcomes in different populations [1]. The used cut-offs had been chosen to allow bal-
anced stratification of trials into subgroups for each outcome analysis. Such categorization
does not build on any specifically outlined risk, as the reporting of potentially underlying risk
factors is often incomplete, but uses the result of these unspecified risk factors, which were as-
sumed to have been allocated to treatment and control group in a balanced manner due to ran-
domization. Furthermore, subgroup-analyses were conducted for trials which did or did not
perform any supragingival debridement in the control group, since such scaling might decrease
any differences between the intervention groups [13]. Meta-regression-analysis was performed
to assess the impact of participants’ average age on the effect estimates using the unrestricted
maximum-likelihood method [14].
Trial sequential analysis
The conventional meta-analysis uses Z-values to compare two interventions, with Z = 0 indi-
cating no difference between groups [15]. If Z exceeds ±1.96, a difference is traditionally as-
sumed to be statistically significant (p0.05, two-sided test). As for repeated updates of meta-
analyses, a new Z-value is calculated for each update. In trial sequential analysis, this series of
Z-values are plotted against the accumulated number of patients, outcomes, or information [5,
16]. This cumulative Z-curve is then assessed regarding its relation to the conventional
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significance boundaries (Z = ±1.96), the required information size, and the trial sequential
monitoring boundaries (TSMB).
In trial sequential analysis, risk of type I error was set at α = 0.05. Risk of type II error was
set at β = 0.20 equivalent to a power of 0.80. Relative risk reduction was defined a priori as a
worthwhile interventional effect of 20% [16]. The resulting required information size was fur-
ther heterogeneity-adjusted (HRIS) using the observed diversity [17].
The Lan-DeMets version [18] of the O’Brien–Fleming function [19] was used for calculating
TSMB. Results crossing the conventional boundary of significance (Z = ±1.96) but not the su-
periority or inferiority TSMB were defined as spuriously significant. Firm evidence of superior-
ity or inferiority was assumed to be reached when the Z-curve crossed the required RIS and the
conventional boundaries hereafter or crossed the superiority or inferiority TSMBs before the
required information size was reached. Firm evidence of futility was confirmed by the Z-curve
crossing the futility TSBM. For meta-analysis or meta-regression-analyses, Comprehensive
Meta Analysis (2.2.064, Biostat, Englewood, NJ, USA) was used. For trial sequential analysis,
TSA 0.9 (Copenhagen Trial Unit, Copenhagen, Denmark) was used [6, 20].
Results
A total of 13 randomized clinical trials evaluating 6283 pregnant women were included. All tri-
als provided data regarding PTB and PNM, whilst only 10 provided data regarding LBW. Attri-
tion was 0% to 11%, with 6037 observations remaining for follow-up. Four trials were judged
as having low risk of bias, the others as having high risk of bias (Table 1).
For PTB, conventional meta-analysis did not find a significant effect of periodontal treat-
ment (OR [95% confidence interval] 0.79 [0.57–1.10]; Fig 1A). Both funnel plot analysis and
Egger’s-test (p<0.05) indicated publication bias (adjusted OR 0.85 [0.60–1.21]). Trials with
low risk of bias did not show a significant effect of periodontal treatment (OR 0.96 [0.54–1.69])
a finding replicated in trials with high risk of bias (OR 0.70 [0.46–1.08]). Patients’ age did not
significantly affect the effect estimates (p>0.05). From the HRIS of 19,656 participants, only
31% (6035) was accrued, with no firm evidence being available. If only populations with mod-
erate occurrence of PTB (<20%) were evaluated, periodontal treatment was not efficacious
(OR 1.12 [0.90–1.39]), and based on trial sequential analysis, future trials might not be able to
prove superiority of periodontal treatment in comparison with placebo for reducing PTB (Fig
1B). In populations with high occurrence of PTB (20%), periodontal treatment seemed to sig-
nificantly decrease the risk of PTB (OR 0.42 [0.57–0.73]), but firm evidence of superiority of
periodontal treatment was not reached (Fig 1C).
For LBW, periodontal treatment had no significant effect (OR 0.69 [0.43–1.13]; Fig 2A).
Funnel plot analysis, but not Egger-test indicated risk of publication bias (p>0.05). The adjust-
ed estimate remained non-significant (adjusted OR 0.73 [0.45–1.19]). Trial with low risk of
bias showed no significant effect of periodontal treatment on LBW (OR 0.92 [0.37–2.31]) in
contrast to trials with high risk of bias (OR 0.58 [0.30–1.13]). This difference was significant
(p<0.05). Patients’ age did not significantly modify the estimate (p>0.05). From the HRIS of
22,476 participants, only 20% (4529) was accrued, with no firm evidence being available. In
populations with moderate occurrence of LBW, periodontal treatment was not found to signifi-
cantly affect risk of LBW (OR 1.14 [0.86–1.53]). Trial sequential analysis found no firm evi-
dence to be currently available supporting or refuting periodontal treatment in such groups
(Fig 2B). For populations with high occurrence of LBW, periodontal treatment seemed to sig-
nificantly decrease LBW (OR 0.32 [0.15–0.67], but firm evidence was not reached (Fig 2C).
Periodontal treatment was not found to significantly reduce the risk of PNM (OR 0.84
[0.57–1.22], Fig 3A). Funnel plot, but not statistical analysis indicated publication bias
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(p>0.05). The adjusted effect estimate remained non-significant (adjusted OR 0.88 [0.61–
1.26]). Neither risk of bias nor patients’ age significantly modified the effect estimate. From the
HRIS of 33,003 participants, only 19% (6149) was accrued, with no firm evidence being avail-
able. Neither in groups with low (<1%) nor high (1%) occurrence of PNM did periodontal
treatment significantly change the risk (OR 0.79 [0.35–1.78] and OR 0.86 [0.57–1.29], respec-
tively). In trial sequential analysis, the Z-curves never crossed the traditional significance
boundaries, and no firm evidence was reached neither for populations with moderate (Fig 3B)
nor high occurrence (Fig 3C).
Regardless of the outcome, excluding trials which had performed supragingival scaling in
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doi:10.1371/journal.pone.0129060.t001
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Fig 1. Periodontal treatment and preterm birth (PTB). (A) Conventional meta-analyses were performed to analyze the effect of periodontal treatment in
control populations with moderate (<20%) and high occurrence (20%) of PTB as well as in the total population. Heterogeneity was assessed using χ2-test
and I2-statistics. (B) Trial sequential analysis of trials in population with moderate occurrence of PTB. The cumulative Z-score (black), i.e., the accumulated
level of significance, was plotted against the number of participants accrued so far, which was compared with the heterogeneity-adjusted required
information size (HRIS). Based on HRIS, the trial sequential monitoring boundary (TSMB) for benefit was plotted (grey oblique). The Z-curve nearly crosses
the futility boundary, and HRIS is not reached. (C) Trial sequential analysis of trials in population with high occurrence of PTB. The Z-curve does not reach the
HRIS, and does not cross the TSMB.
doi:10.1371/journal.pone.0129060.g001
Fig 2. Periodontal treatment and low birth weight (LBW). (A) Conventional meta-analyses were conducted to analyze the effect of periodontal treatment
for populations with moderate (<20%) and high occurrence (20%) of LBW as well as in the total population. (B) Trial sequential analysis of trials in
population with moderate occurrence of LBW. The Z-curve only initially crosses the conventional boundary, with trial sequential monitoring boundary (TSMB)
for benefit and HRIS not being in reach. (C) Trial sequential analysis of trials in population with high occurrence of LBW. The Z-curve does not reach the
HRIS, and does not cross the TSMB.
doi:10.1371/journal.pone.0129060.g002
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Discussion
Traditional meta-analysis might be prone to random errors, especially when evaluating results
of only few early trials with limited quality and small number of patients [2]. In addition, re-
peated significance testing when updating meta-analyses might generate erroneous results [5].
Using both conventional meta-analysis and trial sequential analysis, we show that the general
provision of periodontal treatment does not seem to prevent adverse pregnancy outcomes.
Based on our results, it seems unlikely that firm evidence for such an efficacy will ever be
reached, whilst possible harmful effects cannot be ruled out. Only for high-risk populations,
periodontal treatment appeared potentially efficacious to prevent PTB and LBW, supporting
results from previous analyses [1, 2], whilst trial sequential analysis indicated that firm evi-
dence for this efficacy has not been established so far. For PNM, periodontal treatment was
generally not found efficacious, but trial sequential analysis demonstrated that we have very
sparse data on this outcome.
For LBW and PNM, risk of bias of included trials significantly modified the effect estimates.
It can be argued that none of the trials was of true high risk of bias, as the domain mostly lead-
ing to downgrading of trials to ‘high’ risk of bias was lack of blinding of examiners, i.e., there
was a risk of detection bias. The ascertainment of outcomes like PTB or PNM is most likely not
prone for such bias. However, most trials lacked sufficient allocation concealment as well, and
all included trials might be affected by risk of academic or professional bias [9, 21], which was
not judged within our study. Such bias is overestimation of benefits and underestimation of
harms comparable to industry bias [21], with the difference that explicit and direct financial in-
terests are not present, whilst both indirect financial or non-financial conflicts of interest (com-
petition for public extra-mural support, academic competition, intellectual passion) might be
present, which are far more difficult to assess [22–24]. Considering these limitations and our
results, the summarized evidence is insufficient to support or refute periodontal treatment for
Fig 3. Periodontal treatment and perinatal mortality (PNM). (A) Conventional meta-analyses were conducted to analyze the effect of periodontal
treatment for populations with moderate (<1%) and high occurrence (1%) of PNM as well as in the total population. (B) and (C) Trial sequential analyses of
trials in populations with moderate and high occurrence of PNM, respectively. The conventional boundary, the trial sequential monitoring boundary (TSMB)
for benefit, the TSMB for futility, and the HRIS are not reached.
doi:10.1371/journal.pone.0129060.g003
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reducing adverse pregnancy outcomes. Our findings add weight to previous studies [25–29],
which doubted the association between periodontal treatment and PTB or LBW found by ob-
servational studies [30, 31]. Possible reasons for the discrepancy between results from observa-
tional studies and randomized clinical trials have been discussed elsewhere [25, 31].
The present study has several limitations. First, we performed an update of an existing re-
view, with the inherent risk of having missed studies, i.e., introducing selection bias. Our study
should therefore not be regarded as a systematic review, but as an updated meta-analysis, with
the strength of using a rigorous method for assessing the evidence reached so far, but the weak-
ness of lacking a systematic screening of studies. We have checked for the potential bias of
missing or non-published studies and did not find this to affect our estimates. Second, the used
methods for evaluating the effects of such publication bias (trim-and-fill) should be regarded
with caution as well. Third, we did not exhaustively analyze all possible confounders like com-
mon risk factors or baseline periodontal condition, since extensively performing further sub-
group- and sensitivity-analyses would re-introduce the risk of type I and type II errors, which
we attempted to tackle using trial sequential analysis. One confounder with potential effects on
the efficacy of periodontal treatment for reducing adverse pregnancy outcomes is the provided
care itself. The efficacy of this care has not been demonstrated throughout all included trials
(as not all report on a sufficient set of valid outcomes of periodontal treatment), and different
procedures (non-surgical and surgical, with and without concomitant antibiotic treatment)
and supportive treatments have been provided [32]. Thus, besides having potentially different
effects in different risk groups, the differential provision of periodontal treatment might also
impact on its efficacy for reducing adverse pregnancy outcomes. In future trials, the resolve of
the disease and the associated signs of inflammation should be reported in sufficient detail to
assess the clinical impact of periodontal treatment. This also applies to a third confounder. The
timing of periodontal treatment might determine both its efficacy for reducing signs and symp-
toms of periodontal disease and the associated inflammatory response, thus also impacting on
the potential efficacy for reducing adverse pregnancy outcomes [32].
In conclusion, the main indication for providing periodontal treatment during pregnancy
should be periodontal disease itself [33, 34]. For further recommendations, possible harmful ef-
fects should be first ruled out, and benefits of periodontal treatment should be rigorously dem-
onstrated. To do so, future randomized clinical trials should aim at assessing relevant
confounders, provide efficacious periodontal treatment, and control the effects of this care on
the signs and symptoms of the disease. Multi-center international trials with blinded and inde-
pendent outcome examination might be suited to reach both the required quality and informa-
tion size. Such trials should primarily be conducted in participant groups with high risks, and
methods for reliable identification of such populations should be identified [35–38].
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